Alexis Turner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexis Turner has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Rush
Leeder Centre for Health Policy, Economics & Data, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
2 shared publications - Andrew Wilson
The University of Sydney
2 shared publications - Pippy Walker
Leeder Centre for Health Policy, Economics & Data, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
2 shared publications - Alison Pearce
Daffodil Centre, the University of Sydney, a partnership with Cancer Council New South Wales, Sydney, Australia
1 shared publication - Amber Salisbury
The Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, Australia
1 shared publication - Carmen Huckel Schneider
Menzies Centre for Health Policy and Economics, Sydney School of Public Health, University of Sydney, Sydney, Australia
1 shared publication
Latest Publications
- Open Access
- 29 May 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
The Australian MotherSafe enhanced service for nausea and vomiting in pregnancy and hyperemesis gravidarum: a mixed methods study
Background: Nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG) can have significant physical, psychological and economic impacts on affected women and their families. With the onset of severe symptoms usually occurring in the first trimester and women in Australia typically not engaging in regular antenatal care until beyond this period, there is a gap in access to suitable models of care. In 2023, the MotherSafe teratogen information service introduced an enhanced NVG/HG service that provides medication advice for both over the counter and prescribed medications and psychological support in line with NVP/HG clinical guidelines introduced at a similar time. The aim of this study is to describe service use, patient symptoms and acceptability of the MotherSafe enhanced service for women with NVP and HG in New South Wales (NSW) Australia. Methods: This convergent parallel mixed methods study involved women and family members who contacted the MotherSafe enhanced NVP/HG telephone counselling service from inception (April 2023) to June 2024. Where available, routinely collected service data was analysed to understand service use and changes in NVP symptoms (PUQE-24 score) between the initial and first follow up MotherSafe counselling call ( n = 389). To understand acceptability of the service, semi-structured interviews were conducted with women that had recently accessed the service ( n = 11). Results: During the first 15 months of the enhanced NVP/HG service operation, 1194 initial and 534 follow up MotherSafe counselling calls provided NVP/HG information and advice. Changes in NVP symptoms measured by PUQE-24 scores between initial and follow up call were favourable for women where this data was available ( n = 389, mean score reduction 2.26, p < 0.001), and interview participants reported overall positive experiences that met their needs. Conclusions: The service has the potential to address a health service gap for women with NVP/HG. Further research to more rigorously evaluate change in NVP symptoms following MotherSafe counselling and advice is needed to confirm the effectiveness of the service. Service call numbers and feedback from women suggest that more widespread promotion of the service would support increased reach.
- 29 May 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessThe Australian MotherSafe enhanced service for nausea and vomiting in pregnancy and hyperemesis gravidarum: a mixed methods study
Background: Nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG) can have significant physical, psychological and economic impacts on affected women and their families. With the onset of severe symptoms usually occurring in the first trimester and women in Australia typically not engaging in regular antenatal care until beyond this period, there is a gap in access to suitable models of care. In 2023, the MotherSafe teratogen information service introduced an enhanced NVG/HG service that provides medication advice for both over the counter and prescribed medications and psychological support in line with NVP/HG clinical guidelines introduced at a similar time. The aim of this study is to describe service use, patient symptoms and acceptability of the MotherSafe enhanced service for women with NVP and HG in New South Wales (NSW) Australia. Methods: This convergent parallel mixed methods study involved women and family members who contacted the MotherSafe enhanced NVP/HG telephone counselling service from inception (April 2023) to June 2024. Where available, routinely collected service data was analysed to understand service use and changes in NVP symptoms (PUQE-24 score) between the initial and first follow up MotherSafe counselling call ( n = 389). To understand acceptability of the service, semi-structured interviews were conducted with women that had recently accessed the service ( n = 11). Results: During the first 15 months of the enhanced NVP/HG service operation, 1194 initial and 534 follow up MotherSafe counselling calls provided NVP/HG information and advice. Changes in NVP symptoms measured by PUQE-24 scores between initial and follow up call were favourable for women where this data was available ( n = 389, mean score reduction 2.26, p < 0.001), and interview participants reported overall positive experiences that met their needs. Conclusions: The service has the potential to address a health service gap for women with NVP/HG. Further research to more rigorously evaluate change in NVP symptoms following MotherSafe counselling and advice is needed to confirm the effectiveness of the service. Service call numbers and feedback from women suggest that more widespread promotion of the service would support increased reach.
- Open Access
- 3 October 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-14
A scoping review of models of care and services for nausea and vomiting in pregnancy and hyperemesis gravidarum
Background: Nausea and vomiting in pregnancy and hyperemesis gravidarum have significant physical and psychological impacts on pregnant women. Women are often unable to participate in everyday care and work activities, potentially affecting individual wellbeing and ability to contribute to the economy. Research priorities for hyperemesis gravidarum have been established, however little is known about the current landscape of literature on the health and social care provided to affected women. To inform decision makers on effective models of care and identify remaining evidence gaps, this scoping review aimed to map existing literature that evaluated health and social care delivery arrangements for pregnant women with nausea and vomiting and hyperemesis gravidarum. Methods: Seven databases (Medline, EMBASE, CINAHL, PsycInfo, Maternity and Infant Care, Cochrane Library and Scopus) were searched in August 2023 and again in March 2024 to identify evaluations of health care delivery arrangements for nausea and vomiting in pregnancy and hyperemesis gravidarum. Database searches were supplemented by a Google search for additional peer-reviewed and grey literature. Data from included publications were extracted and synthesised to report on models of care identified, countries, study designs, outcome measures and key findings. Results: Seventy-two records describing 60 separate models of care were identified. Models of care were grouped into hospital settings (n = 34 records), digital health (n = 19 records), group-based care (n = 11 records), and primary care (n = 8 records). Literature in the hospital setting addressed outpatient management (n = 15 records), inpatient management (n = 5 records), comparisons of outpatient and inpatient management (n = 10 records), in-home care (n = 3 records) and emergency departments (n = 1 record). Digital health care evaluations included telephone and web-based support (n = 14 records) and mobile phone applications (n = 5 records). Conclusions: This scoping review has identified the need for further research on approaches to care provision for nausea and vomiting in pregnancy and hyperemesis gravidarum. Whilst some positive findings on patient outcomes, patient experiences and reduced hospital stays resulting from outpatient hospital management pathways were reported, much of this research was observational and limited to UK settings. Other research gaps identified pertained to the effectiveness of primary care, social support and in-home care services, including economic evaluations.
- 3 October 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-14
Open AccessA scoping review of models of care and services for nausea and vomiting in pregnancy and hyperemesis gravidarum
Background: Nausea and vomiting in pregnancy and hyperemesis gravidarum have significant physical and psychological impacts on pregnant women. Women are often unable to participate in everyday care and work activities, potentially affecting individual wellbeing and ability to contribute to the economy. Research priorities for hyperemesis gravidarum have been established, however little is known about the current landscape of literature on the health and social care provided to affected women. To inform decision makers on effective models of care and identify remaining evidence gaps, this scoping review aimed to map existing literature that evaluated health and social care delivery arrangements for pregnant women with nausea and vomiting and hyperemesis gravidarum. Methods: Seven databases (Medline, EMBASE, CINAHL, PsycInfo, Maternity and Infant Care, Cochrane Library and Scopus) were searched in August 2023 and again in March 2024 to identify evaluations of health care delivery arrangements for nausea and vomiting in pregnancy and hyperemesis gravidarum. Database searches were supplemented by a Google search for additional peer-reviewed and grey literature. Data from included publications were extracted and synthesised to report on models of care identified, countries, study designs, outcome measures and key findings. Results: Seventy-two records describing 60 separate models of care were identified. Models of care were grouped into hospital settings (n = 34 records), digital health (n = 19 records), group-based care (n = 11 records), and primary care (n = 8 records). Literature in the hospital setting addressed outpatient management (n = 15 records), inpatient management (n = 5 records), comparisons of outpatient and inpatient management (n = 10 records), in-home care (n = 3 records) and emergency departments (n = 1 record). Digital health care evaluations included telephone and web-based support (n = 14 records) and mobile phone applications (n = 5 records). Conclusions: This scoping review has identified the need for further research on approaches to care provision for nausea and vomiting in pregnancy and hyperemesis gravidarum. Whilst some positive findings on patient outcomes, patient experiences and reduced hospital stays resulting from outpatient hospital management pathways were reported, much of this research was observational and limited to UK settings. Other research gaps identified pertained to the effectiveness of primary care, social support and in-home care services, including economic evaluations.
- Open Access
- 7 February 2025
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 65 (4) , 506-517
Public Perspectives Around Prenatal Screening of Chromosomal Abnormalities: A Focus Group Study Comparing Metropolitan and Rural/Regional Areas in Australia
Background: The widespread and rapid adoption of private payments for non‐invasive prenatal testing (NIPT) in Australia has introduced complexities to the decision‐making process for the public regarding prenatal screening. NIPT has the potential to be a useful screening tool, but concerns have been raised about its cost, the psychological consequences of testing and the information available to support informed decision‐making. Objective: To explore the attitudes, values and beliefs around prenatal screening in Australia, and how perspectives may differ between people living in metropolitan locations versus rural/regional locations. Materials and Methods: Three focus groups were conducted in New South Wales (NSW), Australia. Participants ( N = 25) were recruited by a market research group. Focus groups took place face‐to‐face in metropolitan and rural/regional areas, and online via videoconference. Discussions were transcribed and analysed thematically. Results: Participants generally expressed interest in undertaking prenatal screening but held misconceptions about the purpose of NIPT (i.e. screening, not diagnosis) and the conditions assessed. There were varied opinions among participants on expanding the scope of screening: some felt additional information provided reassurance, whilst others thought it would increase stress due to the decreased accuracy. People living in rural/regional areas had greater concerns over access to screening (cost, wait times and distance) than people living in metropolitan areas. Conclusion: Our findings demonstrate different approaches are needed to improve understanding of NIPT (to ensure informed consent), and to improve access to NIPT for people living in rural/regional areas. The pre‐test information needs to account for the range of perspectives observed across geographic locations.
- 7 February 2025
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 65 (4) , 506-517
Open AccessPublic Perspectives Around Prenatal Screening of Chromosomal Abnormalities: A Focus Group Study Comparing Metropolitan and Rural/Regional Areas in Australia
Background: The widespread and rapid adoption of private payments for non‐invasive prenatal testing (NIPT) in Australia has introduced complexities to the decision‐making process for the public regarding prenatal screening. NIPT has the potential to be a useful screening tool, but concerns have been raised about its cost, the psychological consequences of testing and the information available to support informed decision‐making. Objective: To explore the attitudes, values and beliefs around prenatal screening in Australia, and how perspectives may differ between people living in metropolitan locations versus rural/regional locations. Materials and Methods: Three focus groups were conducted in New South Wales (NSW), Australia. Participants ( N = 25) were recruited by a market research group. Focus groups took place face‐to‐face in metropolitan and rural/regional areas, and online via videoconference. Discussions were transcribed and analysed thematically. Results: Participants generally expressed interest in undertaking prenatal screening but held misconceptions about the purpose of NIPT (i.e. screening, not diagnosis) and the conditions assessed. There were varied opinions among participants on expanding the scope of screening: some felt additional information provided reassurance, whilst others thought it would increase stress due to the decreased accuracy. People living in rural/regional areas had greater concerns over access to screening (cost, wait times and distance) than people living in metropolitan areas. Conclusion: Our findings demonstrate different approaches are needed to improve understanding of NIPT (to ensure informed consent), and to improve access to NIPT for people living in rural/regional areas. The pre‐test information needs to account for the range of perspectives observed across geographic locations.